Bicker U
Cancer Treat Rep. 1978 Nov;62(11):1987-96.
BM 12.531, a 2-cyansubstituted aziridine, has interesting therapeutic and immunomodulating effects. Antitumor effects in Meth A sarcoma in mice and an increase in resistance to Candida albicans infection in mice have been found. It was demonstrated that BM 12.531 can modulate the immune system in animals (DTH lymphocyte transformation, etc). It was also shown that BM 12.531 can restore the immune response in animals, where this has been suppressed by cyclophosphamide. In a phase I study in cancer patients it was demonstrated that BM 12.531 is very well-tolerated. A dose-dependent increase was found in the percentage of spontaneous T lymphocytes in cancer patients after the administration of BM 12.531.
BM 12.531,一种2-氰基取代的氮丙啶,具有有趣的治疗和免疫调节作用。已发现其对小鼠的甲基胆蒽A肉瘤有抗肿瘤作用,并能增强小鼠对白色念珠菌感染的抵抗力。已证明BM 12.531可调节动物的免疫系统(迟发型超敏反应、淋巴细胞转化等)。还表明BM 12.531可恢复免疫系统已被环磷酰胺抑制的动物的免疫反应。在癌症患者的I期研究中,已证明BM 12.531耐受性良好。给予BM 12.531后,癌症患者自发T淋巴细胞的百分比呈剂量依赖性增加。